Jazz Pharmaceuticals PLC | Key People and Executives
Bruce C. Cozadd
Chairman & Chief Executive Officer
Peter Gray
Non-Executive Director
Paul L. Berns
Independent Director
Elmar J. Schnee
Independent Director
Norbert G. Riedel
Independent Director
Seamus C. Mulligan
Independent Director
Heather Ann McSharry
Independent Director
Rick E. Winningham
Lead Independent Director
Ken W. O'Keefe
Independent Director
Patrick G. Enright
Independent Director
Bruce C. Cozadd
Chairman & Chief Executive Officer
Daniel N. Swisher
President & Chief Operating Officer
Paul Treacy
Senior Vice President-Technical Operations
Allen Yang
VP & Therapeutic Area Head-Hematology/Oncology
Iain McGill
Senior Vice President-Jazz Pharmaceuticals Europe
Michael Patrick Miller
Executive Vice President-Commercial
Craig C. Parker
Senior VP & Head-Corporate Development
Peter Gray
Non-Executive Director
Karen J. Wilson
Chief Accounting Officer & SVP-Finance
Jacqueline Pomfret Kirby
VP-Corporate Affairs & Government Relations
Katherine A. Littrell
Vice President-Investor Relations
Heather McGaughey
Senior Vice President-Human Resources
Suzanne Sawochka Hooper
Executive Vice President & General Counsel
Paul L. Berns
Independent Director
Elmar J. Schnee
Independent Director
Norbert G. Riedel
Independent Director
Seamus C. Mulligan
Independent Director
Heather Ann McSharry
Independent Director
Rick E. Winningham
Lead Independent Director
Ken W. O'Keefe
Independent Director
Patrick G. Enright
Independent Director
| Address |
Waterloo Exchange
Dublin Dublin 4
Ireland
|
|
Employees
|
- |
| Website |
http://www.jazzpharma.com |
| Updated |
07/08/2019 |
| Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. |
